bladder cancer gene therapy (MD Anderson Cancer Center)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebladder cancer gene therapy (MD Anderson Cancer Center)
Drug Alias NameRb94 gene therapy (MD Anderson Cancer Center)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionOncogene proteins inhibitors
TargetsOncogene proteins
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A